Rohit Sane
Madhavbaug Clinics & Hospitals, India
Scientific Tracks Abstracts: Altern Integr Med
Objectives: The present study was designed to evaluate effect of heart failure reversal therapy (HFRT) using herbal procedure (panchakarma) and allied therapies, as add-on to standard CHF treatment (SCT) in chronic heart failure (CHF) patients. Methods: This open-label, randomized study conducted in CHF patients (aged: 25ΓΆΒ?Β?65 years, ejection fraction: 30ΓΆΒ?Β?65%), had 3-phases: 1-week screening, 6-week treatment (randomized [1:1] to HFRT + SCT or SCT-alone) and follow-up (12-week). Twice weekly HFRT (60ΓΆΒ?Β?75 min) consisting of snehana (external oleation), swedana (passive heat therapy), hrudaydhara (concoction dripping treatment) and basti (enema) was administered. Primary endpoints included evaluation of change in metabolic equivalents of task (MET) and peak oxygen uptake (VO2 peak) from baseline, at end of 6-week treatment and follow-up at week-18 (non-parametric rank ANCOVA analysis). Safety and Quality of Life (QoL) was assessed. Results: Seventy CHF patients (n=35, each treatment-arm; mean [SD] age: 53.0 [8.6], 80% men) were enrolled in the study. All patients completed treatment phase. Add-on HFRT caused a significant increase in METs (least square mean difference [LSMD], 6-week: 1.536, p=0.0002; 18-week: ΓΆΒ?Β?1.254, p=0.0089) and VO2 peak (LSMD, 6-week: ΓΆΒ?Β?5.52, p=0.0002; 18-week: ΓΆΒ?Β?4.517, p=0.0089) as compared with SCT-alone. Results were suggestive of improved functional capacity in patients with HFRT (QoL; Mean [SD] HFRT + SCT vs. SCT-alone; 6-week: ΓΆΒ?Β?0.44 [0.34] vs. ΓΆΒ?Β?0.06 [0.25], p<0.0001 and 18-week: ΓΆΒ?Β?0.53 [0.35] vs. ΓΆΒ?Β?0.29 [0.26], p=0.0013). Seven treatment-emergent adverse events (mild severity) were reported in HFRT-arm. Conclusion: Findings of this study highlight therapeutic efficacy of add-on HFRT vs. SCT-alone in CHF patients. The noninvasive HFRT showed no safety concerns.
Rohit Sane is the first to conceptualize the idea that ancient Indian medical science, Ayurveda, can play a big role in chronic cardiac disease. Founder of Madhavbaug Clinics & Hospitals in India, he used his education in modern medicine and undertook a meticulous research into Ayurveda. Extensive experimentation and delving deeper into every minute aspect of his study led him to find scientific evidence to substantiate this novel idea. The effort resulted in a combination of modern medical science and the well-established therapies prescribed in Ayurveda, which could prove highly effective alternative way to treat chronic heart failure. Confident about the unique treatment developed by him and named Heart Failure Reversal Therapy, he presented his findings in various international forums
Alternative & Integrative Medicine received 476 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 